SIP 1.55% $1.31 sigma pharmaceuticals limited

I like many data from the report, eg ---------Sigma’s move into...

  1. HSP
    5,051 Posts.
    lightbulb Created with Sketch. 82
    I like many data from the report,
    eg
    ---------Sigma’s move into the China market has proven successful, with sales more than double initial expectations. The company is now looking to push in to the Hong Kong market to leverage off the platform already established in mainland China
    ----------more buyback
    ----------dividends, more than double bank interests
    ----------Sales Revenue growth up 26%
    ----------Underlying EBIT up 12.4%
    --------- Underlying NPAT up 13.0%
    --------- Underlying return on invested capital (ROIC) up to 16.8%----very high
    ----------fully fixed historical problems-----the back yard is clean now
    --------
    --------

    Yes. I believe that it is worth for long investment.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.